Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Recursion Pharmaceuticals insiders completed 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax payment, with the largest single transaction at $149,367.08. Updated 3h ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results